Steven Shum's most recent trade in Expion360 Inc was a trade of 12,195 Common Stock done . Disclosure was reported to the exchange on Aug. 23, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Expion360 Inc | Steven M. Shum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 12,195 | 12,195 | - | 0 | Common Stock | |
NAYA Biosciences | Steven M. Shum | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
Expion360 Inc | Steven M. Shum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 40,000 | 40,000 | - | - | Option | |
NAYA Biosciences | Steven M. Shum | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 57,018 | 57,018 | - | - | Stock Option | |
NAYA Biosciences | Steven M. Shum | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 20,111 | 82,035 | - | 0 | Common Stock | |
NAYA Biosciences | Steven M. Shum | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.26 per share. | 05 Oct 2021 | 30,674 | 61,924 | - | 3.3 | 99,997 | Common Stock |